ALI & Pulmonary HA Deposition After SAH

Официальное название

Relationship Between Acute Lung Injury and Pulmonary Hyaluronic Acid Deposition After Subarachnoid Hemorrhage

Обзор

Acute lung injury is a common complication of subarachnoid hematoma (SAH), and a significant risk factor for death in patients with SAH. Unlike neurogenic pulmonary edema and pneumonia following brain injury, the clinical causes of pulmonary injury after SAH are not intracranial hypertension or pulmonary infection. Its occurrence is influenced by the release of catecholamines, the regulatory function of the hypothalamic-pituitary-adrenal (HPA) axis and systemic inflammatory response, but the specific mechanisms are still unclear. Therefore, delving into the pathological mechanisms of SAH-induced lung injury and developing therapeutic strategies based on the findings is of great importance to improve the prognosis of patients. Abnormal accumulation of hyaluronic acid in the lungs has been reported to be closely related to the pathological progression of various pulmonary injury diseases, such as chest trauma, pulmonary infection and chronic obstructive pulmonary disease. From this, the present research is aimed to explore the levels and dynamic changes of hyaluronic acid in the bronchoalveolar lavage fluid and blood of patients with acute lung injury following SAH, and to analyze its correlation with the prognosis of pulmonary complications, thereby providing assistance for the clinical diagnosis and treatment of SAH.

Первичные конечные точки

• Hyaluronic acid level in bronchoalveolar lavage fluid after SAH [Срок оценки: During the acute phase (1-5 days post-onset) and the chronic phase (10-14 days post-onset) of patients with SAH]
• Inflammatory cytokines levels in bronchoalveolar lavage fluid after SAH [Срок оценки: During the acute phase (1-5 days post-onset) and the chronic phase (10-14 days post-onset) of patients with SAH]

Вторичные конечные точки (2)

• Serum hyaluronic acid level after SAH [Срок оценки: During the acute phase (1-5 days post-onset) and the chronic phase (10-14 days post-onset) of patients with SAH]
• Serum inflammatory cytokines levels after SAH [Срок оценки: During the acute phase (1-5 days post-onset) and the chronic phase (10-14 days post-onset) of patients with SAH]

Критерии участия

Критерии включения

• Age between 18 and 80 years old with independent behavior ability or authorized legal representative.
• A documented diagnosis of SAH within 5 days.
• A Hunt-Hess scale of Ⅳ or Ⅴ.
• Absence of clinical and etiological evidence of pulmonary infection.

Критерии исключения

• Pregnant or lactating women.
• Present history of traumatic brain injury or intracranial hemorrhage.
• Past history of neurological disorders, lung infection within the past six months, cancer, chronic cardiopulmonary diseases, hematological diseases or renal failure.
• Have participated in clinical trials in the past 4 weeks.
• The investigator considers that not appropriate for inclusion.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Модель наблюдения

Когортное

Центры проведения

Китай · 1 центр

• Tianjin Medical University General Hospital — Тяньцзинь

Идентификаторы

NCT: NCT06628531 · IRB2024-YS-425-01

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗